Alert : The site is undergoing maintenance. Some functionality including sign-in may be impacted
Saturday, February 21, 3:00 pm through Tuesday, March 03, 9:00 pm (PST), 2026
Ordering can continue through fax and phone.
Contact us
Alert : The site is undergoing maintenance. Some functionality including sign-in may be impacted
Saturday, February 21, 3:00 pm through Tuesday, March 03, 9:00 pm (PST), 2026
Ordering can continue through fax and phone.
Contact usAlert : The site is undergoing maintenance. Some functionality including sign-in may be impacted
Saturday, February 21, 3:00 pm through Tuesday, March 03, 9:00 pm (PST), 2026
.Ordering can continue through fax and phone.
Contact usThis page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}. You’re currently on the {originCountryName} site. Do you want to switch to a different country site?
Fcγ receptors belong to the immunoglobulin superfamily and are expressed at varying levels by multiple cell lineages, including myeloid and B cells. Different types of Fc receptors modulate a variety of primarily protective immune responses when aggregated by multivalent antigen-antibody complexes. Despite their important physiological role in the immune system, Fc receptors can also bind nonspecifically to detection antibodies in applications such as flow cytometry, causing a false-positive signal during analysis.
BD Biosciences offers a selection of isotype-specific purified recombinant Fc proteins that block nonspecific binding of Fc receptors to antibodies.
The Human BD Fc Block™ Reagent is designed to significantly reduce potential nonspecific antibody staining caused by IgG receptors in various applications, including flow cytometric analysis of human cells. Moreover, because of reduction in nonspecific background staining, the use of the BD Fc Block™ Reagent can make it easy to identify rare target cells such as antigen-specific B cells, fetal cells in maternal blood,
hematopoietic progenitor cells or disaggregated epithelial tumor cells.
FcγII and FcγIII low-affinity receptors for complexed IgG (Fc receptors or FcR) are designated CD32 and CD16, respectively, and expressed on many cell types, including B lymphocytes, NK cells, granulocytes, monocytes, macrophages and platelets. The Fc portions of antibodies may bind to FcR-bearing cells, resulting in nonspecific staining in applications such as flow cytometry.
Mouse BD Fc Block™ Reagent is a purified rat IgG2b anti-mouse CD16/CD32 monoclonal antibody,1 while Rat BD Fc Block™ Reagent is a purified mouse IgG1 anti-rat CD32 monoclonal antibody. Mouse and Rat BD Fc Block™ Reagents can be used to block the Fc-mediated binding of antibodies* to mouse or rat FcR, respectively. The Fc domain of the anti-mouse CD16/CD32 mAb 2.4G2 also binds and blocks the FcγI receptor (CD64).
1. Unkeless JC. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med. 1979;150(3):580-596. doi: 10.1084/jem.150.3.580
Research Use Only. Not for use in diagnostic or therapeutic procedures.